Secondary hyperparathyroidism (Q39838): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Hiperparatireoidismo secundário é uma condição com aumento da secreção de PTH e níveis elevados de PTH na circulação causado por alterações metabólicas como hipocalcemia, hiperfosfatemia e níveis baixos de 1,25 hidroxivitamina D.
description / endescription / en
 
Secondary hyperparathyroidism is a condition with enhanced parathyroid hormone (PTH) secretion and high circulatory PTH level caused by metabolic changes such as hypocalcaemia, hyperphosphataemia and low 1,25-dihydroxyvitamin D.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1442752937 / rank
 
Normal rank
Property / CURIE
 
CID11:5A51.1
Property / CURIE: CID11:5A51.1 / rank
 
Normal rank
Property / Canary Token
 
dki-india-5A51.1
Property / Canary Token: dki-india-5A51.1 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: E21.1 / rank
 
Normal rank

Latest revision as of 05:23, 13 August 2026

Secondary hyperparathyroidism is a condition with enhanced parathyroid hormone (PTH) secretion and high circulatory PTH level caused by metabolic changes such as hypocalcaemia, hyperphosphataemia and low 1,25-dihydroxyvitamin D.
Language Label Description Also known as
default for all languages
5A51.1
    English
    Secondary hyperparathyroidism
    Secondary hyperparathyroidism is a condition with enhanced parathyroid hormone (PTH) secretion and high circulatory PTH level caused by metabolic changes such as hypocalcaemia, hyperphosphataemia and low 1,25-dihydroxyvitamin D.

      Statements

      CID11:5A51.1
      0 references
      dki-india-5A51.1
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references